A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Clinical trial NCT07165028 · RECRUITING

Trial details

NCT number: NCT07165028
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease

Start date: 2025-10-15
Primary completion: 2030-08-01
Enrollment: 4500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.